St. Jude Medical (NYSE:STJ) does not often do flashy deals, but the company has a solid track record of buying just-under-the-radar companies with strong positions in lucrative niche markets. St. Jude rolled out that formula again on Monday, announcing a cash and stock deal for AGA Medical (Nasdaq:AGAM) - a small-cap med-tech company with a great franchise in niche applications of cardiac structural repair and vascular abnormalities.

IN PICTURES: 9 Simple Investing Ratios You Need To Know

The Deal
To bring AGA Medical into the fold, St. Jude is paying about $1.1 billion in a mix of cash and stock, and assuming over $200 million in AGA Medical debt. All told, St. Jude is facing a $1.3 billion price tag, while AGA Medical shareholders get about $20.80 per share divided equally between cash and stock. In order to neutralize the impact of these shares, St. Jude's board also authorized a share repurchase program of up to $600 million. (For more, see The Wacky World Of Mergers And Acquisitions.)

At $20.80, AGA Medical shareholders are getting a better than 40% premium to Friday's closing price. Moreover, the deal values AGAM at over six times 2010 estimated revenue - not quite back to the levels of 8 - 10 times sales seen in the heyday of med-tech M&A at the turn of the century, but a nice premium all the same.

What St. Jude Is Buying
In AGA Medical, St. Jude is buying the leader in catheter-based minimally invasive treatments for many congenital structural defects of the heart. While AGA Medical has a lion's share of this roughly $250 million market, the real value in AGA Medical is its pipeline. The company is pursuing technologically similar minimally invasive approaches to treating patent foramen ovules (PFO) - a heart defect implicated in strokes and migraines. Other R&D efforts include vascular stent grafts and cardiac plugs for left arterial appendage (LAA). All in all, these are four shots on goal for four $1 billion-plus markets. (For more, see A Checklist For Successful Medical Technology Investment.)

Stronger In Cardiology
With this deal, St. Jude definitely strengthens its cardiology franchise - an area that until recently had pretty much gone to sleep in terms of investor and corporate interest. Now, though, Medtronic (NYSE:MDT) and Edwards Lifesciences (NYSE:EW) have investors' attention with their transcatheter heart valves, and Volcano (Nasdaq:VOLC) is showing there is a real business in both intravascular ultrasound imaging and functional measurement (which, technically, is electrophysiology and/or cardiac imaging and not cardiology).

The Bottom Line
It is improbable that this is the start of a new wave of med-tech M&A, any more than relatively recent deals by Medtronic and Covidien were the start of a new wave. Big companies are always on the prowl for innovative approaches that can capture and hold significant marketshare. What it means for investors, though, is that there is real value in small and mid-cap medical technology companies that fit that description - companies doing something new and innovative, treating real problems and possessing the quality and competence to grab real market share. (For more, see Investing In Medical Equipment Companies.)

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

Related Articles
  1. Economics

    Investing Opportunities as Central Banks Diverge

    After the Paris attacks investors are focusing on central bank policy and its potential for divergence: tightened by the Fed while the ECB pursues easing.
  2. Stock Analysis

    The Biggest Risks of Investing in Pfizer Stock

    Learn the biggest potential risks that may affect the price of Pfizer's stock, complete with a fundamental analysis and review of other external factors.
  3. Stock Analysis

    Allstate: How Being Boring Earns it Billions (ALL)

    A summary of what Allstate Insurance sells and whom it sells it to including recent mergers and acquisitions that have helped boost its bottom line.
  4. Options & Futures

    Cyclical Versus Non-Cyclical Stocks

    Investing during an economic downturn simply means changing your focus. Discover the benefits of defensive stocks.
  5. Markets

    PEG Ratio Nails Down Value Stocks

    Learn how this simple calculation can help you determine a stock's earnings potential.
  6. Investing Basics

    How to Deduct Your Stock Losses

    Held onto a stock for too long? Selling at a loss is never ideal, but it is possible to minimize the damage. Here's how.
  7. Investing

    What’s the Difference Between Duration & Maturity?

    We look at the meaning of two terms that often get confused, duration and maturity, to set the record straight.
  8. Economics

    Is Wall Street Living in Denial?

    Will remaining calm and staying long present significant risks to your investment health?
  9. Stock Analysis

    When Will Dick's Sporting Goods Bounce Back? (DKS)

    Is DKS a bargain here?
  10. Investing News

    How AT&T Evolved into a Mobile Phone Giant

    A third of Americans use an AT&T mobile phone. How did it evolve from a state-sponsored monopoly, though antitrust and a technological revolution?
  1. What does low working capital say about a company's financial prospects?

    When a company has low working capital, it can mean one of two things. In most cases, low working capital means the business ... Read Full Answer >>
  2. Do nonprofit organizations have working capital?

    Nonprofit organizations continuously face debate over how much money they bring in that is kept in reserve. These financial ... Read Full Answer >>
  3. Can a company's working capital turnover ratio be negative?

    A company's working capital turnover ratio can be negative when a company's current liabilities exceed its current assets. ... Read Full Answer >>
  4. Does working capital measure liquidity?

    Working capital is a commonly used metric, not only for a company’s liquidity but also for its operational efficiency and ... Read Full Answer >>
  5. How do I read and analyze an income statement?

    The income statement, also known as the profit and loss (P&L) statement, is the financial statement that depicts the ... Read Full Answer >>
  6. Can working capital be too high?

    A company's working capital ratio can be too high in the sense that an excessively high ratio is generally considered an ... Read Full Answer >>

You May Also Like

Trading Center